Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Markers of Disease and Response to Therapy

NCT04118153 is registered in ClinicalTrials.gov with Sandra Lord, MD as lead sponsor.

NCT NCT04118153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04118153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Markers of Disease and Response to Therapy
Lead sponsor
Sandra Lord, MD
Phase
Phase 1
Overall status
Completed
Start date
March 5, 2021
Completion date
May 24, 2024
Enrollment
60 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes